Daniel S. Goldberg has devoted his career to studying how laws affect public health. When the COVID-19 pandemic hit, legal and ethical considerations played critical roles in crafting public health policy and protecting the most vulnerable. Goldberg saw a need to better explore the interplay of public health law and ethics – as well as opportunities for improving health justice – and launched the PHEAL program at the Colorado School of Public Health with the Center for Bioethics and Humanities.
A biopharma that markets an ADHD medication, and sells a portfolio of over-the-counter consumer health products on Amazon and elsewhere, has decided to scrap all work on clinical-stage assets. The Englewood, CO-based biotech will do […]
Seasoned Cancer Research Fellow with specialized interest in Reverse Phase Protein Array Technology to bolster Theralink’s management team GOLDEN, Colo., Nov. 7, 2022 /PRNewswire/ — Theralink Technologies, Inc. (OTC: THER) (“Theralink” or the “Company”), a […]
InnovAge made a big splash with its IPO in March 2021. A year and a half later, its enrollment was capped in two different states because of resource shortages, and its stock price had fallen […]
Copyright © 2026 Biotech Networks
